Literature DB >> 1825620

Analysis of T cell receptor beta and gamma genes from peripheral blood, regional lymph node and tumor-infiltrating lymphocyte clones from melanoma patients.

M R Albertini1, J A Nicklas, B F Chastenay, T C Hunter, R J Albertini, S S Clark, J A Hank, P M Sondel.   

Abstract

A total of 199 T cell clones from two melanoma patients were derived from progenitor T cells from recurrent melanoma, regional lymph nodes (either involved or uninvolved with malignancy) and peripheral blood by inoculating single cells directly into the wells of microtiter plates before in vitro expansion. The surface marker phenotype of most clones was CD4+CD8-, although some were CD4-CD8+. Genomic DNA prepared from all clones was analyzed by Southern blot hybridization using T cell receptor (TCR) beta and gamma gene probes, seeking clones with identical TCR gene rearrangement patterns as direct evidence for in vivo progenitor T cell clonal amplification. Probing HindIII-digested DNA with TCR beta and TCR gamma probes revealed several clones with identical TCR gene rearrangement patterns. These clones had subsequent probing of BamHI-digested DNA with TCR beta and TCR gamma probes, which showed all but 2 clones to have distinct rearrangement patterns. These analyses provide clear molecular evidence for in vivo polyclonal CD4+ T cell populations in each of several separate immune compartments in these patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1825620     DOI: 10.1007/bf01789051

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  35 in total

Review 1.  The antigen-specific, major histocompatibility complex-restricted receptor on T cells.

Authors:  P Marrack; J Kappler
Journal:  Adv Immunol       Date:  1986       Impact factor: 3.543

2.  Rearrangement of two distinct T-cell gamma-chain variable-region genes in human DNA.

Authors:  M P Lefranc; A Forster; T H Rabbitts
Journal:  Nature       Date:  1986 Jan 30-Feb 5       Impact factor: 49.962

3.  Recognition of a purified Mr-40,000 organ-specific immunogen of human lung cancer by class II-restricted T-cells.

Authors:  D M Thomson; M Sutherland; R Scanzano; G Shenouda
Journal:  J Natl Cancer Inst       Date:  1987-10       Impact factor: 13.506

Review 4.  The T cell receptor.

Authors:  P Marrack; J Kappler
Journal:  Science       Date:  1987-11-20       Impact factor: 47.728

5.  Molecular analyses of in vivo hprt mutations in human T-lymphocytes. I. Studies of low frequency 'spontaneous' mutants by Southern blots.

Authors:  J A Nicklas; T C Hunter; L M Sullivan; J K Berman; J P O'Neill; R J Albertini
Journal:  Mutagenesis       Date:  1987-09       Impact factor: 3.000

6.  Induction by interleukin-2 of oligoclonal expansion of cultured tumor-infiltrating lymphocytes.

Authors:  A J Fishleder; J H Finke; R Tubbs; R M Bukowski
Journal:  J Natl Cancer Inst       Date:  1990-01-17       Impact factor: 13.506

7.  Preferential clonogenic deficit of CD8-positive T-lymphocytes infiltrating human solid tumors.

Authors:  S Miescher; M Stoeck; L Qiao; C Barras; L Barrelet; V von Fliedner
Journal:  Cancer Res       Date:  1988-12-15       Impact factor: 12.701

8.  A human T cell-specific cDNA clone encodes a protein having extensive homology to immunoglobulin chains.

Authors:  Y Yanagi; Y Yoshikai; K Leggett; S P Clark; I Aleksander; T W Mak
Journal:  Nature       Date:  1984 Mar 8-14       Impact factor: 49.962

9.  Presence on a human melanoma of multiple antigens recognized by autologous CTL.

Authors:  B Van den Eynde; P Hainaut; M Hérin; A Knuth; C Lemoine; P Weynants; P van der Bruggen; R Fauchet; T Boon
Journal:  Int J Cancer       Date:  1989-10-15       Impact factor: 7.396

10.  Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.

Authors:  K Itoh; C D Platsoucas; C M Balch
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

View more
  7 in total

1.  Human blastocysts exhibit unique microrna profiles in relation to maternal age and chromosome constitution.

Authors:  Blair R McCallie; Jason C Parks; Alyssa L Strieby; William B Schoolcraft; Mandy G Katz-Jaffe
Journal:  J Assist Reprod Genet       Date:  2014-04-24       Impact factor: 3.412

Review 2.  Tumor-infiltrating lymphocytes: their phenotype, functions and clinical use.

Authors:  T L Whiteside; G Parmiani
Journal:  Cancer Immunol Immunother       Date:  1994-07       Impact factor: 6.968

3.  Oligoclonality of CD8+ T cells in breast cancer patients.

Authors:  K Ito; J Fetten; H Khalili; S Hajdu; E Busch; R Pergolizzi; V Vinciguerra; M D Chang
Journal:  Mol Med       Date:  1997-12       Impact factor: 6.354

4.  T-cell receptor V delta gene usage by tumour reactive gamma delta T lymphocytes infiltrating human lung cancer.

Authors:  M R Zocchi; M Ferrarini; N Migone; G Casorati
Journal:  Immunology       Date:  1994-02       Impact factor: 7.397

5.  Interleukin-4 plus tumor necrosis factor alpha augments the antigenicity of melanoma cells.

Authors:  D S Hoon; Y Hayashi; T Morisaki; L J Foshag; D L Morton
Journal:  Cancer Immunol Immunother       Date:  1993-11       Impact factor: 6.968

6.  T cell avidity and tumor recognition: implications and therapeutic strategies.

Authors:  Mark D McKee; Jeffrey J Roszkowski; Michael I Nishimura
Journal:  J Transl Med       Date:  2005-09-20       Impact factor: 5.531

7.  T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.

Authors:  M Sensi; S Salvi; C Castelli; C Maccalli; A Mazzocchi; R Mortarini; G Nicolini; M Herlyn; G Parmiani; A Anichini
Journal:  J Exp Med       Date:  1993-10-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.